Cantor Fitzgerald Reiterates Exagen (XGN) Overweight Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on August 22, 2023, Cantor Fitzgerald reiterated coverage of Exagen (NASDAQ:XGN) with a Overweight recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1203882906-bf6db82c0c7d42c6a29b7f1f9115af15.jpg "2025 Social Security Tax Limit")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1137410599-27899a879c9b470aba0c43f8790870ad.jpg "Deadlines for 2025 Estimated Taxes")